OsimertinibDevelopment of resistance in non-small cell lung cancer: 3 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1880卷 / 1期
关键词：
D O I：
10.1007/s40278-021-05145-1
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：311 / 311
相关论文
共 50 条
  • [31] Afatinib/erlotinib/gefitinibDevelopment of resistance to tyrosine kinase inhibitors in non-small cell lung cancer: 123 case reports
    Reactions Weekly, 2021, 1847 (1) : 27 - 27
  • [32] Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer
    Bar, Jair
    Ofek, Efrat
    Barshack, Iris
    Gottfried, Teodor
    Zadok, Oranit
    Kamer, Iris
    Urban, Damien
    Perelman, Marina
    Onn, Amir
    LUNG CANCER, 2019, 138 : 109 - 115
  • [33] Mechanisms of resistance to pemetrexed in non-small cell lung cancer
    Liang, Jiaqi
    Lu, Tao
    Chen, Zhencong
    Zhan, Cheng
    Wang, Qun
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 1107 - 1118
  • [34] Mechanisms of resistance to chemotherapy in non-small cell lung cancer
    Min, Hye-Young
    Lee, Ho-Young
    ARCHIVES OF PHARMACAL RESEARCH, 2021, 44 (02) : 146 - 164
  • [35] Biomarkers for immunotherapy resistance in non-small cell lung cancer
    Rother, Catriona
    John, Tom
    Wong, Annie
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [36] Mechanisms of resistance to chemotherapy in non-small cell lung cancer
    Hye-Young Min
    Ho-Young Lee
    Archives of Pharmacal Research, 2021, 44 : 146 - 164
  • [37] Appendicitis while on alectinib for non-small cell lung cancer: a tale of two case reports
    Wheatley-Price, Paul
    Wong, Boaz
    Shah, Hely
    Sekhon, Harman
    Moore, Sara
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [38] CrizotinibDevelopment of resistance during treatment for non-small cell lung cancer: case report
    Reactions Weekly, 2017, 1666 (1) : 91 - 91
  • [39] Afatinib/erlotinib/gefitinibAcquired resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2018, 1705 (1) : 15 - 15
  • [40] Gefitinib/osimertinibAcquired resistance in advanced non-small cell lung cancer: case report
    Reactions Weekly, 2021, 1863 (1) : 165 - 165
12345